Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
The CII recognition further strengthens Molecules Biolabs’ position as a rising innovation leader in India’s life sciences and nutraceutical space
Molecules Biolabs has been recognised among the Top 50 Intellectual Property (IP) Companies in India by the Confederation of Indian Industry (CII), placing the young innovation-driven company alongside some of the country’s most established industry leaders.
The recognition highlights the company’s robust IP ecosystem and its leadership in liposomal supplement research and advanced delivery technologies, areas in which Molecules Biolabs has built a strong scientific and patent-driven foundation.
“This achievement truly belongs to our exceptional team,” said Dr Sreeraj Gopi, Founder and Managing Director, Molecules Biolabs. “Their passion, scientific rigor, and unwavering commitment to innovation have been the driving force behind this recognition. It reflects the depth of our research, the quality of our intellectual property, and our long-term vision.”
Dr Gopi also expressed gratitude to the broader ecosystem that supported the company’s journey, including team members, customers, professors, collaborators, and well-wishers across the globe.
The CII recognition further strengthens Molecules Biolabs’ position as a rising innovation leader in India’s life sciences and nutraceutical space and serves as motivation for the company to continue pushing the boundaries of science-driven innovation.
Molecules Biolabs is a research-led life sciences company from Kerala with a strong focus on intellectual property creation and advanced R&D. The company has developed a robust IP portfolio in formulation science and liposomal delivery technologies, driven by in-house research and strategic academic collaborations. Its innovation-led approach emphasizes translating high-quality science into protected, scalable solutions.